Rixensart, Belgium

Philippe Vincent Hermand

USPTO Granted Patents = 8 


 

Average Co-Inventor Count = 5.0

ph-index = 5

Forward Citations = 48(Granted Patents)


Company Filing History:


Years Active: 2015-2022

Loading Chart...
Loading Chart...
Loading Chart...
8 patents (USPTO):Explore Patents

Title: Inventor Spotlight: Philippe Vincent Hermand

Introduction:

Philippe Vincent Hermand, a talented inventor based in Rixensart, Belgium, has made significant contributions to the field of immunology with a total of 8 patents to his name. His innovative work in developing pneumococcal capsular saccharide conjugate vaccines has garnered attention and recognition in the scientific community.

Latest Patents:

1. Pneumococcal capsular saccharide conjugate vaccine: Philippe's latest invention focuses on an immunogenic composition tailored specifically for infants. The vaccine comprises multiple capsular saccharide conjugates from different serotypes, including a vital serotype 22F saccharide conjugate. This groundbreaking vaccine aims to reduce the incidence of elderly pneumococcal diseases such as COPD exacerbations and IPD.

2. Vaccine: Another notable invention by Philippe involves an immunogenic composition containing capsular saccharide conjugates from serotypes 19A and 19F. These saccharides are conjugated to distinct bacterial toxoids, offering a novel approach to vaccine development and usage.

Career Highlights:

Philippe Vincent Hermand is a valued member of GlaxoSmithKline Biologicals SA, a renowned pharmaceutical company known for its groundbreaking research in immunization and healthcare. His dedication to enhancing vaccine efficacy and accessibility has propelled him to the forefront of vaccine innovation.

Collaborations:

In his pursuit of impactful inventions, Philippe has collaborated with esteemed colleagues such as Jan Poolman and Ralph Leon Biemans. These collaborations have fostered a culture of creativity and knowledge-sharing, leading to the development of cutting-edge immunological solutions.

Conclusion:

Philippe Vincent Hermand's inventive spirit and commitment to advancing vaccine technology through his patents have left an indelible mark on the healthcare industry. His innovative contributions continue to drive progress in immunization, ultimately benefiting global health outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…